NCT06922539
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06922539
Title ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SciTech Development, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Southern California RECRUITING Los Angles California 90007 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field